Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Opasnet Co., Ltd. (173130:KRX), powered by AI.
Opasnet Co., Ltd. is currently trading at ₩7,770. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Opasnet Co., Ltd. on Alpha Lenz.
Opasnet Co., Ltd.'s P/E ratio is 8.0.
“Opasnet Co., Ltd. trades at a P/E of 8.0 (undervalued) with strong ROE of 21.4%. 3Y revenue CAGR of 11.0% highlights clear growth momentum.”
Ask for details →Opasnet Co., Ltd. is an innovative healthcare technology company primarily focusing on developing and providing advanced medical solutions. The company's primary function is to create cutting-edge medical devices and healthcare systems that enhance the delivery and quality of healthcare services across various medical fields. Opasnet Co., Ltd. is instrumental in the medical technology sector, with specialties that include diagnostic equipment, imaging devices, and health informatics systems. By leveraging its expertise in research and development, the company continuously seeks to improve the efficiency and effectiveness of healthcare practices. This technological contribution is significant in the financial market, as Opasnet Co., Ltd. plays a pivotal role in advancing global healthcare standards, making healthcare more accessible and efficient. The company's commitment to innovation positions it as a key player in shaping the future of medical technology.
“Opasnet Co., Ltd. trades at a P/E of 8.0 (undervalued) with strong ROE of 21.4%. 3Y revenue CAGR of 11.0% highlights clear growth momentum.”
Ask for details →Opasnet Co., Ltd. (ticker: 173130) is a company listed on KRX in the Technology sector (Information Technology Services). It has approximately 386 employees. Market cap is $101.4B.
The current price is ₩7,770 with a P/E ratio of 8.01x and P/B of 1.57x.
ROE is 21.36% and operating margin is 6.02%. Annual revenue is $233.3B.